Typicality: | 0.375 |
Saliency: | 0.294 |
for females ages 9 to 26 | 2 | transitive-object |
vaccine → be licensed in → 2006 | 14 |
vaccine → be approved in → 2006 | 12 |
negative | neutral | positive |
0.118 | 0.662 | 0.220 |
Raw frequency | 26 |
Normalized frequency | 0.294 |
Modifier score | 0.500 |
Perplexity | 48.830 |